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Abstract  
Over a period of 2007-2011 188 stomach cancer (SC) patients have been included in the 
research in abdominal oncosurgical department of Odessa regional oncological dispensary. It 
was retrospective, one-center, nonrandomized research. Volume of lymph node dissections 
differed by quantity of lymph nodes to be removed. All patients were divided into three groups. 
Patients with D1 or D1+ lymph node dissections have been performed, totally 90 patients are 
included in group of historical control. The main group includes 33 patients to whom D3 lymph 
node dissections is executed and, finally, control group – 65 patients dissected up to the D2 
volume. In all cases so-called lymph node dissections for principal reasons have been executed. 
The multifactorial analysis of patients survival is implemented depending on a type of a lymph 
node dissections, a stage of the cancer, number of involved lymph nodes, involvement of the 
tumoral microcirculatory net (ly is carried out, v) signs of a perinevral invasion (Nev), 
availability of residual tumoral tissue (R), degree of a differentiation (G). Regardless of a disease 
stage, SC at 60% of patients, represented with initially hematologicaly disseminated disease. 
40% of SC`s had no signs of intratumoral microcirculatory net involvement even in case of more 
than 15 regional lymph nodes are involved.  In the absence of a SC perinevral invasion appeared 
to be the most precise predictive marker.  The conclusion is made some brand new additional 
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prognostic factors could play a crucial role in more accurate patients selection for expanded 
lymph node dissections.  
Keywords: stomach cancer, extended lymph node dissections. 
 
Introduction 
Removal of lymph nodes as collectors of regional metastasis leaves a standard procedure 
at various locations of malignancies. The concept of "dissection" includes removal of lymph 
nodes, lymph vessels, and fat, located near these structures. Regional lymph node dissection is a 
standard surgical maneuver in stomach cancer (SC). The consequence of lymph collectors 
dissection has elaborated in the fundamental provisions on SC (General Rules for Gastric Cancer 
Study) published by the Japanese research society for gastric cancer (Japanese Research Society 
for Gastric Cancer – JRSGC). For the first time, according to the literature single block removing 
of local cancer metastasis was performed at the beginning of the 60-ies of the 20 century by 
D.Jinnai. 
   At present, depending on the volume of dissection of lymphatic tissue in SC, there are 
three variants of gastrectomy [2]: 
1. Standard gastrectomy, which runs D1 dissection, including paragastric lymph nodes: 1-
6 of the Japanese classification of regional lymph nodes. 
2. Radical gastrectomy, with D2 lymph node dissection, including lymph collectors 
located along the branches of the celiac artery: 7-11 lymph nodes. 
3. Advanced radical gastrectomy, includes 12-16 retroperitoneal lymph nodes. 
Retroperitoneal metastases in the lymph nodes under the 6th Edition of UICC TNM 
belong to category M1. According to the international classification and the domestic guides [2] 
to the group of regional lymph nodes rank regional lymph nodes groups 1-12. Most of the lymph 
nodes of N3 category JRSGC in accordance with the classification of the International Cancer 
Union belongs to category M1, fourth stage of SC.       
V.I.Chissov et al., referred to the category D2 lymph node dissection removing 1 – 12 
groups, D3-13 – 16 groups, including No. 16a1, 16a2, 16b1 [2]. D4-paraaortal lymph node – 
dissections from the lower level to the bifurcation of the aorta mesenteric artery – No. 16b2. This 
is the fundamental difference of approach to expanded lymph node dissections and JRSGC 
standards. At the same time, analysis of the literature shows that there is a slow but steady 
tendency to the escalation of removing lymph node groups quantity towards D3 and N3 category 
[1]. 
According to the standards JGCA, Gastric Cancer Association Japanese [5] provides 4 
types of radical surgical resection of the stomach: modified gastrectomy, standard gastrectomy 
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and extended or advanced gastrectomy. Respectively modified gastrectomy and D1 + lymph 
node dissection volume corresponds to the removal of 7 groups of lymph nodes, lymph nodes 
along the left gastric artery. Modified gastrectomy in accordance of this classification includes 
the removal of 7, 8A and 9 groups of lymphatic nodes. To clarify should we perform D2 or D3 
dissection we detail the location of the tumor in the stomach. Table 1 shows the classification of 
radical surgical resections according to Japanese Research Society for Gastric Cancer. 
 
Table  1.  Types of radical surgical resection according to JRSGC 
Type of 
operation 
 
Type of 
operation 
 
Type of lymph node dissection Options 
Endoscopic 
mucous 
resection 
Mucousectomy no no 
Modified 
gastreсtomy, 
 type А 
Partial 
gastreсtomy,  
Total resection 
 
D1+ lymph nodes along the left gastric 
artery 
Preservation of a 
vagal nerve, 
pylorus-sparing, 
laparoscopic 
Modified 
gastreсtomy,  
type В 
Partial 
gastreсtomy,  
Total resection 
 
D1+lymph nodes along the left gastric 
artery, lymph nodes along the forward 
groups along the general hepatic 
artery, lymph nodes along of celiac 
artery 
no 
Conventional Total resection 
 
D2 – removal of lymph nodes 
corresponding to tumor localization in 
a stomach, but always 7, 8а, 9, 11 
groups; according to indications: 
lymph nodes of regional groups 10 
(UML, UM, U*), 11d (UM, U*), 12а 
(UML, LD, L, M, ML, MU*), 14v 
(UML, L, LD*) 
no 
Advanced Total 
resection, 
Extended total 
resection 
 
D3 – always 8b, 16a2, 16b1, 12b, 12p;  
according to indications: lymph nodes 
of regional groups 10 (M, ML*), 11d 
(M, ML*), 12a (U*), 14v (M, ML, 
UM*), 19 (UML, MU, U*), 20 (UML, 
UM, U*), 110,111, 112 (E*)  
no 
 
* Specification of the stomach parts: U – the top third of the stomach, M – within the middle 
one-third of the stomach, L – the lower third of the stomach, E – esophagus, D – duodenum. 
 
   In accordance with the recommendations of the JGCA execution of transactions 
connected with SC. Thus, in case of 1A stage the correct radical procedure could vary from 
endoscopic mucosa resection to the standard gastrectomy. Therefore, specific operational choice 
depends on the TNM stage. 
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1. Stage 1A, T1N1Mo: Endoscopic mucosal resection or modified gastrectomy.  
Table 2. Summarized treatment recommendations for 1A stage of stomach cancer (SC).   
Invasion depth Histological type Tumor size Type of operation 
 
Mucous Well differentiated 
tumor 
 
Less 2,0см Endoscopic 
mucous resection 
More 2,0см Modified 
gastreсtomy, type 
А 
Mucous Poorly differentiated 
tumor 
- Modified 
gastreсtomy, type 
B 
Submucous Well differentiated 
tumor 
Less 1,5 см Modified 
gastreсtomy, type 
А 
Submucous Poorly differentiated 
tumor 
- Modified 
gastreсtomy, type 
B 
   
      Endoscopic resection is indicated for patients with a tumor without the regional lymph 
nodes involvement. According to JGCA, intestinal SC type with localization in mucosa, the size 
of less than 2 cm to be considered has no metastases in regional lymph nodes. Endoscopic single 
block resection of the stomach mucosa has certain advantages, but because of the high risk of 
recurrence after endoscopic resection 2 cm is the limiting threshold for this operation. Clear 
assessment of invasion depth, histological phenotype and size of the tumor is obligatory for 
endoscopic operation. In the case of mucous limited SC does not satisfy those requirements, 
modified gastrectomy or subtotal resection of the stomach, type A (MG-A) should be performed. 
MG-A also indicated in the case of well-differentiated gastric cancer less than 1.5 cm in 
diameter. In the case of submucosal SC, meets these requirements, modified gastrectomy or 
subtotal resection of the stomach, type B in (MG-B) should be done. 
    In case of the lower third of the stomach to remove 8A groups of lymph nodes (front 
upper panel along the common hepatic artery) is not shown. 
2. Phase 1b, T1N1Mo, T2NoMo 
   Modified type of gastrectomy or standard gastrectomy are indicated for the 1B stage of 
SC depending on case T and N categories. It is considered in the presence of T1N1Mo tumor 
lesser than 2.0 cm in diameter, performing modified type of gastrectomy is preferable. In the 
presence of T1N1Mo tumor larger than 2.1 cm or meets the criteria T2NoMo, typical 
gastrectomy is acceptable. Table 3 summarizes treatment recommendations for 1B stage. 
 
 
56 
 
Table 3. Algorithm of treatment of SC in 1B. 
Invasion depth Tumor size Lymph 
nodes 
involvement 
Type of operation 
 
T1 (mucous, submucous) Less 2,0см N1 Modified gastreсtomy, type B 
T1 (mucous, submucous) 2,1 cm and more N1 Standard gastreсtomy 
 
T2 (own muscular cover, 
subserous) 
2,1 cm and more No Standard gastreсtomy 
 
 
3. Stage 2, T1N2Mo, T2N1Mo, T3NoMo 
Standard gastrectomy is indicated for 2
nd
 stages of SC, regardless of T and N categories.  
 
Table 4. The algorithm of treatment for stage 2 SC. 
Depth of 
invasion 
Lymph nodes involvement Type of operation 
 
Т1 N2 Standard gastreсtomy 
Т2 N1 Standard gastreсtomy 
Т3 Nо Standard gastreсtomy 
 
    Adjuvant chemotherapy is recommended since 2
nd
 stage of SC, however even till now 
there is no approved treatment guidelines for postoperative adjuvant chemotherapy. It is 
necessary to conduct clinical studies to confirm the standard mode of adjuvant of treatment in 
SC. 
4. Stage 3a, T2N2Mo, T3N1Mo, T4NoMo 
   Standard or extended GE are preferable for stage 3A SC depending on T and N 
categories, as it is shown in the table. Table 5 summarizes treatment recommendations 3A stage 
SC. 
 
Table 5. The algorithm of treatment stage 3A SC. 
Depth of 
invasion 
Lymph nodes involvement Type of operation 
 
Т2 N2 Standard gastreсtomy 
Т3 N1 Standard gastreсtomy 
Т4 Nо Advanced gastreсtomy 
 
     It is necessary to conduct clinical research at this stage of the SC in order to establish 
precise indications for adjuvant treatment. In the case of T4 combined resection of involved 
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adjacent structures and/or the adjuvant radiotherapy might be indicated in order to reduce 
potential risk of residual tumor arising. 
5. Stage 3B, T3N2Mo, T4N1Mo 
   Standard or extended GE indicated in stage 3B of SC, according of T and N indexes, as it 
is shown in the following table. Although the effect of D3 lymph node dissection as a surgical 
intervention for N2 tumors is not totally clear yet, the D3 has been frequently utilizing in routine 
practice in Japan [5]. Novel treatment recommendations for stage 3B SC management are listed 
in the table #6. 
 
Table 6. The algorithm of treatment stage 3B, RJ. 
Depth of 
invasion 
Lymph nodes involvement Type of operation 
 
Т3 N2 Standard gastreсtomy 
Т4 N1 Advanced gastreсtomy 
 
   Multiple organ resections in the case of neighbor organ involvement are indicated in the 
T4 SC in order to obtain Ro operation. The issue of adjuvant and neoadjuvant radiotherapy or 
chemotherapy still remains not fully clarified. 
6. Stage 4-N3, CY1, M1. 
   Most cases of SC 4 stage cannot be radically cured by doing surgery alone, except that 
the N3 or T4N2Mo tumor. If N3 presence is the sole determining factor for stage 4, D3 operation 
might be potentially effective to run Ro resections. Table 7 shows the total Protocol radical 
surgical treatment of SC. 
 
Table 7. TotalTreatment Protocol for SC [5]. 
 No N1 N2 N3 
1 2 3 4 5 
T1(M) IA 
Endoscopic 
mucous 
resection  
IB 
Modified 
gastreсtomy, 
type B or 
Standard 
gastreсtomy 
II 
Standard 
gastreсtomy 
IV 
Advanced or 
palliative 
gastreсtomy, 
Chemoradiotherapy 
or Palliative care 
T1(SM) IA 
Modified 
gastreсtomy, 
type A or type B 
T2 IB 
Standard 
gastreсtomy 
II 
Standard 
gastreсtomy, 
adjuvant 
chemotherapy 
IIIA 
Standard 
gastreсtomy, 
adjuvant 
chemotherapy 
T3 II 
Standard 
IIIA 
Standard 
IIIB 
Standard 
58 
gastreсtomy, 
adjuvant 
chemotherapy, 
adjuvant 
radiotherapy 
gastreсtomy, 
adjuvant 
chemotherapy 
gastreсtomy, 
adjuvant 
chemotherapy 
 
1 2 3 4 5 
T4 IIIA 
Advanced 
gastreсtomy, 
adjuvant 
chemotherapy, 
adjuvant 
radiotherapy 
IIIB 
Advanced 
gastreсtomy, 
adjuvant 
chemotherapy, 
adjuvant 
radiotherapy 
 
M1 IV 
 
     However, in view of the fact that the set of patients in the study is dated 2007-2011, we 
applied the domestic classification. If you take a principled position, in accordance with JRSGC, 
our group D3 lymph node dissections D2 + group you can name. Differences with the D2 arm 
remains totally clear and transparent: an additional 13-15 lymph nodes groups dissection. 
Objectives 
The objectives of this work were to compare the influence of different types of operations 
to patients’ survival rate.   
Materials and methods  
A study carried out on the basis of abdominal oncosurgery department of Odessa regional 
oncologic dispensary, 188 patients operated on for stomach cancer in the period 2007-2011 have 
analyzed retrospectively. The study was retrospective, single-center, non-randomized, includes 
only the radical or shareware radically operated patients. The average age was 60.6 ± 10.5 years, 
gender distribution: 120 men, 68 women. The detailed distribution of patients by age is presented 
in table 8. 
 
Table 8. Distribution of Gastric Cancer Patients by Age Group. 
№ Age group Number 
of 
patients 
1. 30-39 years 7 
2. 40-49 years 21 
3. 50-59 years 54 
4. 60-69 years 63 
59 
5. 70-79 years 35 
6. 80-90 years 5 
 
 
126 total gastrectomy and 62 distal subtotal resection were included into the list. Total 
gastrectomies were performed according to Bondar method [10] with the formation of the anti-
reflux terminal-lateral mufti-like retro-colic esophago-jejunum anastomosis loop with entero-
anastomose according to Brown methodic. Distal subtotal resection was accomplished in the 
most cases by performing retro-colic gastroenteroanastomosis by Goffmeister-Finsterer 
according to Bilroth-2 modification. 
Majority of these operations were accompanied by multiple organ resections. Colon, 
liver, pancreas, diaphragm, abdominal wall, left and right kidneys, right and left adrenal glands, 
small intestine, retroperitoneal space considered as an adjacent for stomach structures [4]. 
Intraparietal spread into  esophageal wall is noted at 31 (16.49%) the patient, requiring resection 
of the subdiaphragmatic and, in some cases, intradiaphragmatic esophageal segments. In 3 cases, 
Osawa-Harlock operation with resection of distal esophageal segment was performed. In 28 
cases – resection of the subdiaphragmatic segment by Savinykh. Intraparietal spread to the 
duodenum was found in 2 (1.06%) patients and were being classified by the maximal depth of 
invasion evaluated morphologically. Resection of the pancreatic tail met the 74 patients 
(39.36%) however true histological invasion into the pancreas found in 5 patients (2.66%), 
atypical liver resection in 9 patients (4.79%), anatomical resection-3 patients (1.59%). 
Splenectomy was done in 153 cases (81.38%), most frequent as a principal approach, as a 
component of D1 + lymph node dissection. In 5 cases there was metastatic spleen capsule 
affection (2.66%). In 3 cases carried out dissection of the gate of the spleen as a part of spleen-
saving operation (1.59%). 
Survival rate of our patients has been studied. Statistic calculations were carried out using 
ANOVA (analysis of variance) by implementing the statistical program SSP set to evaluate the 
strength of the correlation between the groups utilizing the linear correlation coefficient by 
Pearson. To assess the credibility of different groups – coefficient Wilcockson test has been 
utilized. Comparison of survival by Cox regression is not reasonable. It was estimated the 
cumulative duration of lifespan after treatment, evaluated in months (absolute numbers). 
The conclusions were made by p Wilkoxon less than 0.05, which is considered sufficient 
for biological and medical investigations. The correlation was considered to be high if the index 
R Pearson's 0.7 – 0.9, very high-more than 0.9, see (Table 9). 
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Table 9. Interpretation of the Pearson Product Moment Correlation Coefficient. 
Value Interpretation  
Up to 0,2  Very poor correlation 
Up to 0,5  Poor correlation 
Up to 0,7  Mild correlation 
Up to 0,9  Strong correlation 
 Beyond 0,9  Very strong correlation 
 
Lymph node dissections were classified by number of distant lymph nodes to be 
dissected. All the patients were divided into three groups. A group of historical control patients 
whom D1 or D1 + lymph node dissection were performed, 90 patients. The main group consisted 
of 33 patients whom D3 dissection was completed, the comparison group – 65 patients with D2 
dissection. The results are presented in the table #10. 
 
Table 10. Number of Removed Lymph Nodes, Depending on the Type of Operation, the Number 
of Operations. 
Type of operation 
 
Type of lymph node 
dissection 
Average number of 
lymph nodes to be 
removed   
Number  
of operations 
1. Standard D 1 8,9 ± 0,9 90 
2. Radical D 2 31,6 ± 0,7 65 
3. Advanced 
gastreсtomy 
D 3 37,9 ± 0,9 33 
 
Each removed tissue have examined histologically. Distribution of distant lymph node 
groups by JGCA classification began to do recently. Removed lymph nodes have been ranked in 
7 groups: paragastric of large curvature (# 4-6), paragastric of small curvature (# 1, 3, 5), lymph 
nodes along the branches of the splanchnic trunk (# 7-11), renal and hepatic ligaments of the 
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liver and duodenum (# 12), retropancreatic (# 13), the root of the mesentery of large intestine  
(#14-15), aortic lymph nodes (# 16). Paraaortal dissection was performed to the level 16a2. 
Still remains unclear the question should the resection of splenic artery during (and the 
distal hemipancreatosplenectomy as a matter of principle, oncological reason) with arcade Kirk 
as stage D2 lymph node dissection to be executed. 
For staging used 6-th Edition of TNM classification, distribution of patients in stages is 
presented in Table 11. 
 
Table 11. Distribution of Gastric Cancer Patients in Stages. 
Stage TNM, 6-th 
edition 
Number of patients 
According to stage According to рTNM 
Absolute 
values 
Percentage Absolute 
values 
Percentage 
1А рT1NоMо 1 0,53 1 0,53 
1В рT1N1Mо 14 7,45 0 0 
рT2аNоMо 14 7,45 
рT2bNoMo 0 0 
2 рT1N2Mo  14 7,45 0 0 
рT2aN1Mo 1 0,53 
рT2bN1Mo 4 2,13 
рT3NoMo 9 4,78 
3А рT2aN2Mo 60 31,91 1 0,53 
рT2bN2Mo 4 2,13 
рT4NoMo 24 12,77 
рT3N1Mo 31 16,49 
3В рT3N2Mo  14 7,45 14 7,45 
4 рT4N1Mo 85 45,21 25 13,29 
рT4N2Mo 32 17,02 
рT4N3Mo 15 7,98 
рT1N3Mo 0 0 
рT2aN3Mo 
рT2bN3Mo 
3 1,59 
рT3N3Mo 5 2,66 
рTлюбоеNлюбоеM
1 
5 2,66 
 
  Where rT1 – tumor of the stomach, infiltrates the basal membrane and the submucosal layer; 
rT2a – tumor, infiltrates muscular layer; 
rT2b – tumor, infiltrates subserous layer; 
rT3 – tumor, infiltrates serosa layer (visceral peritoneum) invasion into nearby structures; 
rT4 – tumor spreads to nearby structures. 
In table 12 presents the characteristics of patients according to the degree of the local prevalence 
of SC. 
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Table 12. Characteristics of Patients According to the Degree of the Local Prevalence of SC. 
 
 Т - criteria Number of patients 
in absolute values 
Percentage 
рТ1 1 0,53 
рТ2a 17 9,04 
рТ2b 10 5,32 
рТ3 61 32,45 
рТ4 99 52,66 
  
In cases when tumor has a large and (or) small epiploon, gastro-colic ligament (or) 
gastro-hepatic ligament, spreading into the muscular layer of the stomach wall, without 
perforation of the visceral peritoneum, the tumor has been classified as T2. In 4 cases, the tumor 
perforates visceral peritoneum, which covers the ligaments of stomach or epiploon has been 
classified as T3. 
According to the TNM classification of 6 regional lymph nodes were located along the 
small and the large curvature, left gastric, hepatic and splenic artery, splanchnic trunk and 
hepato-duodenal. 
No-there are no signs of regional lymph nodes in the study at least 15 delivered the 
lymph nodes; 
N1-metastasis in 1-6 regional lymph nodes; 
N2-metastasis in 7-15 regional lymph nodes; 
N3-metastasis to more than 15 lymph nodes.      
Distant metastases were classified as standard, as Mo – in the absence of distant 
metastases and M1-defined – in the presence of distant metastases. Retroperitoneal metastases in 
lymph nodes, as mentioned above, also attributed to category M1. 
 
Histopathological grading (G): 
G1-highly differentiated tumor; 
G2- moderately differentiated tumor; 
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G3- poorly differentiated tumor  
G4: undifferentiated (anaplastic) a tumor. 
Gx- degree of tumor differentiation. 
The characteristics of the patients according to the degree of differentiation SC present in Table 
13. 
Table 13. Distribution of Patients with Tumor Differentiation of SC. 
Histopathological 
grading 
Number of 
patients  
Percentage 
G1 5 2,66 
G2 86 45,75 
G3 80 42,55 
G4 17 6,92 
 
For the convenience of further calculations of survival and stratification of patients they 
were divided into groups with differentiated cancers, which include highly – and moderately 
differentiated tumors and patients with poorly differentiated tumor forms: it included low and 
undifferentiated gastric cancers. The number of patients with differentiated forms of cancers – 91 
(48.40%), with undifferentiated – 97 (51.59%). 
Patients with macroscopically-defined residual tumor tissue had not been included in the 
study R2, R1 residual tumor was found in 31 patients (16.5%). In addition to determining the 
degree of differentiation of the primary tumor, tumor incidence in the stomach, invasion into 
surrounding structures, etc., was the number of the affected lymph node groups Nos. 1-16, 
presence of tumor emboli in capillary veins (v.), signs of perinevral invasion (Nev) [6], the 
presence of residual tumor tissue (R). 
 
The degree of vascular (v, a venous and lymphatic, ly) involvement by JRSGC [5]: 
v0, ly0-no vascular invasion; 
v1, ly1-minimal vascular invasion; 
v2, ly2-moderate vascular invasion; 
v3 ly3 is expressed (heavy) vascular invasion. 
 
The reason for the lack of differentiation of venous and lymphatic invasion of 188 
patients was the painting of micro preparates by hematoxylin-eosin (H&E), while according to 
the literature [5] for the follow-up of differences is Victoria-blue staining or Elastica stainig, 
which we didn't have. Pathomorphological venous and lymphatic vessels tracked the type of 
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muscular walls (venules with optical microscopy more muscle, lymphatic vessels have the 
appearance of fissure). Capillary vessels without a muscular component to distinguish, in most 
micropreparations only capillaries. Differentiation of the tumor by microscopic infiltration INF 
(α-, β-, γ-type type) as well. On the degree of involvement of the microcirculatory net in the 
tumor process (invasion in micro venaes and lymph capillaries, the presence of tumor emboli – 
OE) patients were divided into Vo and V1. In the group of Vo patients included v0-1, ly0-1 
tumors; Group V1 v2-3 patients, ly2-3 tumors. This is to avoid too many patient`s groups with a 
small number of patients in each group. Table 14 shows the distribution of SC in stages 
depending on the presence of tumor emboli (OE). 
 
Table 14. The distribution of patients in stages, depending on the availability of the MA in 
microvasal a tumor. 
Stage Presence emboli in a vascular environment Ratio of occurrence 
of a sign in a stage Vo V1 
Absolute 
values 
Percentage Absolute 
values 
Percentage 
1А 1 0,53% 0 0% 0% 
1В 13 6,91% 1 0,53% 7,14% 
2 7 3,72% 7 3,72% 50% 
3А 43 22,87% 17 9,04% 28,33% 
3В 13 6,91% 1 0,53% 7,14% 
4 67 35,64% 18 9,58% 21,18% 
Sum 144 76,59% 44 23,40% 23,4% 
   
Results 
Patients who underwent less than 15 lymph nodes removing during gastrectomy or 
subtotal gastrectomy was only in the historical controls. Unfortunately, in modern conditions is 
difficult to manufacture and study 30-40 frozen sections obtained from one operational 
preparation (D3 = 40 removed lymph nodes), which sought to combine the intra-operative 
cytological and histological study. We has been performed only one section of each removed 
lymph node (by JGCA research it is essential to do at least three slices of each remote lymph 
node). 
Postoperative lethality was 4.3%. The highest mortality was in Group D3 – 6.1%. There 
has been a gradual decline in the fatality rate during the experience has been grown up in recent 
years, the death rate after gastrectomy was 2%. In any case, among the 188 patients, mortality 
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was not related to the leakage of esophago-jejunoanastomosis or duodenum. Immediate 
treatment results are presented in table 15. 
 
 
 
Table 15. Postoperative lethality depending on the type of operation. 
Type of operation 
 
Number of the 
dead, absolute 
values 
Percentage 
D1-lymph node 
dissection procedure 
3 3,3% 
D2-lymph node 
dissection procedure 
3 4,6% 
D3-lymph node 
dissection procedure 
2 6,1% 
 
Patient`s survival rate was monitored using Odessa regional cancer registry. 2 patients 
were excluded from the list, 4 – have died from other causes. 
The frequency of vascular involvement in the study was 23.4%: 44 of 188 studied 
patients. The presence of OE in a vascular tumor microenvironment is not always correlates to 
the stage of the disease [7]. A small number of patients with present histological examination 
found MA in stage 3B, perhaps due to the small sample size – 14 persons; as well as the 
presence of two neighboring groups – 3A and 4 stages patients with phenotype T4NanyMo. Such 
tumors are prone to hematogenic dissemination more than to local growth. 3A stage, which 
consisted of patients with rT2aN2Mo, rT2bN2Mo, rT4NoMo, rT3N1Mo SC phenotypes, 
correlates by absolute number of V1 4 group stage patients (with more advanced rT4N1Mo, 
rT4N2Mo, rT4N3Mo, rT1N3Mo, rT2aN3Mo, rT2bN3Mo, rT3N3Mo, as well as tumors with 
macroscopically-defined hematogenic dissemination TanyNanyM1). This difference in the 
pathohistological picture in the earlier stages witness a different biological properties of cancers 
than the impact correct staging (all macro-and microscope slides were explored and staged by 
the same pathologist). The same trend can be seen and in the study of the prevalence of 
perinevral growth at various stages of SC. The number of N + tumor in 3A and 4 stages is the 
same. 
In examining cross-dependence correlation of stage and the absence of OE in these 
microvessels RVo = 0.59 (SEE = 1.35, p = 0.038) and almost complete independence in the 
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interaction between of tumor stage and OE: R = 0.42 (SEE = 1.59, p = 0.083). This conclusion 
was totally unexpected, statistical error probability evaluation was 1.59. Thus, this allows us to 
consider SC as a primarily haematogenously-disseminated disease. This conclusion is confirmed 
by the studying correlation of prevalence the sign in the stage. A significant involvement of 
microvessels most often met in 2
nd
 and 3
rd
 stages. Tumor emboli were already present in stage 
1B, i.e. rT1N1Mo, rT2aNoMo, rT2bNoMo stages. To control this thesis the circulating in the 
bloodstream of malignant cells study is essential. 
Lack of micro vessels involvement also correlates the perinevral growth deficiency: R = 
0.98 (SEE = 4.41, p = 0.0001), highlights the complete absence of correlation between the 
perinevral and perivasal growth: R = 0.21 (SEE = 25.35, p = 0.178). Indeed, the perinevral 
growth is a variant of the local growth of tumor tissue, indicating the proliferative potential of 
SC. At the same time, perivasal growth characterizes metastatic potential ability of hematogenic 
dissemination.  
High close to absolute, the direct relationship between Vo and the absence of residual 
tumor tissue Ro (R = 0.95, SEE = 6.46, p = 0.0005) characterizes by tumors, regardless of the 
stage had no propensity to metastasize hematogenic. Such tumors better respond to surgical 
intervention. It is in this group lymph node dissection for SC provide positive results. Extremely 
high negative correlation absence of perivasal growth and microscopically detected residual 
tumor tissue R1 (R = 0.97, SEE = 4.67, p = 0.0001) indicates the same. The absence of indirect 
signs of hematogenic dissemination in 4th stage in 35.64 percent manifests about the positive 
perspective of lymph node dissection even at the advanced stage. The 4 – stage tumors were 
rTanyN3Mo, i.e. nearly 40% of the SC did not have perivasal growth even if 15 regional lymph 
nodes involved. The same can be said of 36 patients with tumors that have stage 3A histological 
phenotype rT2a-2bN2Mo and rT3N1Mo. 5 patients with metastases in the lymph nodes, 15-7 
and 31 patient with 1-6 affected regional lymph nodes did not have perivasal growth on 
histological examination. 
In the second stage, characterized by the presence of phenotypes rT1N2Mo, rT2aN1Mo, 
rT2bN1Mo, rT3NoMo, 7 patients with SC had a significant vascular lesion. In spite of this, the 
survival rate after radical treatment in this group of patients was 34.1 of the month, an average 
survival rate of these patients was about 3 years. The survival of patients after D3 in 2 stages of 
SC – 48 months, after D2 – 20.3 months and 34 months after the standard resection of the 
stomach and gastrectomy. However, in the absence of perivascular growth when D1 lymph node 
dissection patients lived in 2 stages approximately 32 months, perivascular growth presence – 24 
months, when V + tumors combined with D2 lymph node dissection 18.5 months when 
performing standard operations – 24 months. There was revealed a high correlation between the 
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survival of patients with perivascular growth present and three other indicators. No. 1-the 
survival of patients with tumors G1\G2 SC (R = 0.87, p = 0.4, SEE = 3.7). No. 2-the survival of 
patients with Ro-operations (R = 0.8, p = 0.0000, SEE = 3.95). No. 3-relationship with the 
survival of patients with tumors with Nev\0 phenotype (R = 0.89, p = 0.0000, SEE = 3.05). 
Regardless of the stage, perivascular growth presence was directly linked to the perinevral 
spread of tumors – R=0.83. Inverse proportionality with strong perivascular growth has been 
observed in the absence of perinevral growth and Ro – resections. I.e. the more perivascular 
growth was expressed, the less likely Ro-resection could be done, and vice versa. 
The more there is, the more often the perivascular growth was, etc. In the study of life 
expectancy is not dependent on the stage and type of performed operation duration of 
observation About patients, 23.6 ± 5.6 months, not statistically different from the duration of the 
observation of the V1, 19.2 ± 5.6 months (p = 0.25, F = 129). Traced the influence of type of 
operation performed on the life expectancy of patients depending on the presence of perivascular 
growth. So the D3 dissection increased the survival rate of patients with SC in Vo 1A and 3A, 
V1-2 SC patients, 3A, 4 stages. The advantage of pliable distal tip advances easily over D1 D2 
by the criterion of duration of observation of the patients mentioned in the Vo patients SC in 3A 
and 4 stages, with V1-3A. 
Perinevral growth research depends on the type of operations, duration of patient follow-
up, the number of removed lymph nodes, degree of tumor differentiation. Table 16 shows the 
distribution of SC patients in stages, depending on the availability of perinevral tumor 
infiltration. 
 
Table 16. The distribution of patients in stages, depending on the availability of microscopically 
by perinevral growth. 
Stage Perinevral growth Ratio of 
occurrence of 
a sign in a 
stage 
No N1 
Absolute 
values 
Percentage Absolute 
values 
Percentage 
1А 1 0,53% 0 0% 0% 
1В 13 1,59% 1 0,53% 7,14% 
2 6 3,72% 8 3,72% 57,14% 
3А 55 29,26% 5 2,66% 8,33% 
3В 13 6,91% 1 0,53% 7,14% 
4 80 42,55% 5 2,66% 5,88% 
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Sum 168 89,36% 20 10,64% 10,64% 
 
     20 of 188 examined histological preparations had signs of perinevral invasion, as an early 
sign of high potential of early local relapse of SC and potential of perinevral tumor 
generalization. An unusually high percentage of perinevral growth in 2
nd
 stag seems to be due to 
the fact that 9 out of 14 patients had rT3NoMo phenotype. Total cross-linkages between criteria 
G, V, R, Nev, as well as the stage of SC, type of lymph node dissection and survival is shown in 
table 17. 
Table 17. Cross connection between criteria G, V, R, Nev., as well as the stage of SC, depth of 
completed lymph node dissection and survival. 
 G1\G2 G3\G4 Vо V1 Rо Nev\0 Nev\1 Stage 
ST 
Type of op 
G1\G2 - - R=0,87 
p=0,4 
SEE=3,7 
R=0,2 
p=0,0001 
SEE=9,1 
R=0,79 
p=0,27 
SEE=4,7 
R=0,9 
p˂0,001 
SEE=3,2 
R=0,14 
p=0,1 
SEE=9,41 
R=0,28 
p=0,03 
SEE=8,66 
R=0,6 
p=0,0024 
SEE=4,7 
G3\G4 - - R=0,18 
p=0,08 
SEE=11,5 
R=0,37 
p=0,01 
SEE=10,1 
R=0,06 
p=0,2 
SEE=12,3 
R=0,1 
p=0,15 
SEE=12,0 
R=0.0006 
p=0,47 
SEE=12,7 
R=0,23 
p=0,05 
SEE=11,2 
R=0,03 
p=0,3 
SEE=12,1 
Vо R=0,87 
p=0,4 
SEE=3,7 
R=0,18 
p=0,08 
SEE=11,5 
- - R=0,8 
p=0,0000 
SEE=3,95 
R=0,89 
p=0,0000 
SEE=3,05 
R=0,12 
p=0,13 
SEE=8,57 
R=0.3 
p=0,03 
SEE=7,6 
R=0,38 
p=0,02 
SEE=4,1 
V1 R=0,2 
p=0,0001 
SEE=9,1 
R=0,37 
p=0.01 
SEE=10,1 
- - R=0,12 
p=0,13 
SEE=10,4 
R=0,11 
p=0,13 
SEE=10,4 
R=0,3 
p=0,03 
SEE=9,36 
R=0,19 
p=0,08 
SEE=9,96 
R=0,13 
p=0,23 
SEE=9,1 
Rо R=0,79 
p=0,27 
SEE=4,7 
R=0,06 
p=0,2 
SEE=12,3 
R=0,8 
p˂0,001 
SEE=3,95 
R=0,12 
p=0,13 
SEE=10,4 
- R=0,89 
p=0,0000 
SEE=2,84 
R=0,09 
p=0,15 
SEE=7,97 
R=0,19 
p=0,06 
SEE=7,5 
R=0,96 
p˂0,001 
 
SEE=0,83 
R1 R=0,0002 
 
R=0,0003 
p=0,5 
SEE=12,7 
R=0,0001 
p=0,5 
SEE=9,1 
R=0,05 
p=0,22 
SEE=10,7 
- R=0,01 
p=0,38 
SEE=16,1 
R=0,14 
p=0,1 
SEE=14,9 
R=0,19 
p=0.37 
SEE=14,6 
R=0,12 
p=0,32 
SEE=15,6 
Nev\0 R=0,9 
p˂0,001 
SEE=3,2 
R=0,1 
p=0,15 
SEE=12,0 
R=0,89 
p˂0,001 
SEE=3.05 
R=0,11 
p=0,13 
SEE=10,4 
R=0,89 
p˂0,001 
SEE=2,84 
- - R=0,25 
p=0,04 
SEE=8,62 
R=0,82 
p˂0,001 
SEE=2,9 
Nev\1 R=0,14 
p=0,1 
SEE=9,41 
R=0,0006 
p=0,47 
SEE=12,7 
R=0,12 
p=0,13 
SEE=8,57 
R=0,3 
p=0,03 
SEE=9,36 
R=0,09 
p=0,15 
SEE=7.97 
- - R=0,0009 
p=0,46 
SEE=11,9 
R=0,005 
p=0,42 
SEE=11,7 
Type of 
op 
R=0,6 
p=0,0024 
 
R=0,03 
p=0,3 
 
R=0,38 
p=0,02 
 
R=0,13 
SEE=9,1 
R=0,96 
p˂0,001 
SEE=0,83 
R=0,82 
p˂0,001 
SEE=2,9 
R=0,005 
p=0,42 
SEE=11,7 
R=0,03 
p=6,29 
 
- 
 
Index R is the numeric value of coefficient of Pearson linear correlation, p-reliability, 
SEE-the standard error of calculations. Absence of perinevral growth in the study was the most 
sensitive factor with direct correlation, which is close to 1.0 in relation to the absence of 
perivasal growth with likelihood of radical resection, i.e. favorable predicting factors (R = 0.98, 
SEE = 4.41, p = 0.0001). Identified an inverse proportional dependence between Nev and the 
presence of perivasal growth as well as residual tumor tissue presence.  
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The presence of perinevral growth does not correlate with any predicting factors, i.e., it 
was not a significant prognostic factor. The influence of lymph node dissection type has impact 
on a survival rate of patients depending on the stage of the SC. The degree of this influence was 
evaluated based on the presence/absence perinevral tumor growth. D3 dissection increased the 
survival rate of patients with SC Nev\0 at 1B and 3A stages, D2 dissection in Nev\0 gave an 
advantage in 2
nd
 and 3
rd
 stages. The advantage of lymph node dissection at Nev\0 in 4
th
 stage 
were not statistically proved. In the perinevral tumor growth present, that is Nev/1, D3 dissection 
has had a positive effect on the survival rate in 2
nd
 and 3
rd
 stages, and D2 dissection increased 
survival only in 3A, Nev/1 stage.  
In 1a, Nev/1 and 3B, Nev/1 stages of SC examined groups were too small. The difference 
in life expectancy depending on perinevral growth, regardless of the stage depth and lymph node 
dissection is as follows. Life expectancy at Nev\0 – 24.6 ± 6.0 months and for Nev\1 – 12.9 ± 6.0 
months (p = 0.0092, F = 882). Thus, regardless of correlation with other factors, perinevral 
growth believed to be the negative predicting factor. Table 18 shows the distribution of patients 
in stages, depending on the availability of R1. 
 
Table 18. The distribution of patients in stages, depending on the availability of microscopically 
defined residual tumor tissue. 
Stage Availability of microscopically defined residual tumor 
tissue 
Ratio of 
occurrence of 
a sign in a 
stage 
Ro R1 
Absolute 
values 
Percentage Absolute 
values 
Percentage 
1А 1 0,53% 0 0% 0% 
1В 14 2,13% 0 0% 0% 
2 13 7,98% 1 0,53% 7,14% 
3А 50 26,59% 10 5,32% 16,67% 
3В 12 6,38% 2 1,06% 14,29% 
4 67 35,64% 18 9,57% 21,18% 
Sum 157 83,51% 31 16,49%  
 
Conclusions 
1. 60% of SC patients, irrespectively of the stage of the disease, had obviously 
haematogenously disseminated disease: R = 0.42 (SEE = 1.59, p = 0.083). 
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2. 40% SC had no signs of microcirculatory net involvement even in the case of 
metastases present in more than 15 regional lymph nodes. 
3. The absence of perinevral cancerous infiltration was manifested as the most sensitive 
test, with a statistic power of correlation close to 1.0 to the lack of dissemination and likelihood 
of hematogenic radical resection, i.e. favorable way for SC follow up (R = 0.98, SEE = 4.41, p = 
0.0001). 
4. It is essential to find some novel predicting markers for further correct selecting 
patients for advanced lymph node dissections. 
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